Novagold Resources Inc. vs uniQure N.V. Ordinary Shares — how do they compare? Novagold Resources Inc. trades at $6.37 (market cap $2.73B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B). The key difference: Novagold Resources Inc. is the larger of the two by market cap, and Novagold Resources Inc. is more actively traded (6,599,188 versus 3,323,243). Which is the better fit depends on your goals — on Pluang, investors hold Novagold Resources Inc. for 0 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| NG | QURE | |
|---|---|---|
Market Cap | $2.73B | $1.45B |
Volume | 6,599,188 | 3,323,243 |
Sector | Basic Materials | Health |
52-Week High | $14.20 | $70.59 |
52-Week Low | $5.18 | $9.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.57B | $707.46M |
Signals from Pluang's Aura AI — not financial advice
NovaGold Resources (NG) trades at $6.63, down 1.49% today, as the company navigates its development phase for the Donlin Gold project. The stock shows mixed earnings performance with recent quarterly losses but beats expectations in two of the last four quarters. Financials reveal negative profitability metrics with ROE at -32.81% and net income of -$94.66M for 2025, though cash flow remains positive due to financing activities. Recent news highlights the company's move to acquire full ownership of Donlin Gold, a major Alaska gold project.
The outlook for NG hinges on successful development of Donlin Gold, with 100% analyst buy ratings signaling strong Wall Street confidence. However, significant execution risks exist given negative earnings and substantial capital requirements. Investors face volatility from gold price fluctuations and project development timelines, making this suitable for those with high risk tolerance seeking exposure to a major gold development story.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
NovaGold Resources Inc. is a mineral exploration and development company that holds a majority interest in the Donlin Gold project, an undeveloped gold deposit in Alaska.
Read more on NG →uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →